Back to announcement
20250423_BMHS_Laporan Informasi dan Fakta Material_31877461.pdf
Other Text extracted BMHSSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 020-K/CORSEC/BMHS/IV/2025
Nama Perusahaan PT Bundamedik Tbk
Kode Emiten BMHS
Lampiran 1
lnformasi Rencana Periode Pelaksanaan Tahap I Window Exercise I dan
Perihal
Tahap II Window Exercise I Tahun 2025 Program Management and Employee
Stock Option Program (MESOP) PT Bundamedik Tbk
Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:
Nama Emiten atau Perusahaan Publik PT Bundamedik Tbk
Bidang Usaha Aktivitas rumah sakit swasta
Telepon (62-21) 3192-3344
Faksimili (62-21) 3190-5915
Alamat Surat Elektronik (email) corsec@bmhs.co.id
Tanggal Kejadian 23 April 2025
Jenis Informasi atau Fakta Material lnformasi Rencana Periode Pelaksanaan Tahap I Window
Exercise I dan Tahap II Window Exercise I Tahun 2025
Program Management and Employee Stock Option Program
(MESOP) PT Bundamedik Tbk
Uraian Informasi atau Fakta Material 1. Periode Pelaksanaan Tahap I Window Exercise I dan Tahap
II Window Exercise I : 30 (tiga puluh) hari bursa terhitung sejak
tanggal 1 Mei 2025 sampai dengan tanggal 20 Juni 2025
2. Harga Pelaksanaan Tahap I Window Exercise I yang Telah
Ditetapkan Sebelumnya: Rp. 863 per lembar
3.Harga Pelaksanaan Tahap II Window Exercise I : Rp. 363
per lembar
4. Jumlah Hak Opsi yang Dikonversi Untuk Periode
Pelaksanaan Tahap I Window Exercise I : Jumlah Hak Opsi
yang Dikonversi untuk Periode Pelaksanaan sebanyak-
banyaknya 22.500.000 saham dan Hak Opsi yang belum
Dikonversi pada Periode Pelaksanaan ini dapat dilakukan
pada periode pelaksanaan berikutnya
5. Jumlah Hak Opsi yang Dikonversi Untuk Periode
Pelaksanaan Tahap II Window Exercise I : Jumlah Hak Opsi
yang Dikonversi untuk Periode Pelaksanaan sebanyak-
banyaknya 2.500.000 saham dan Hak Opsi yang belum
Dikonversi pada Periode Pelaksanaan ini dapat dilakukan
pada periode pelaksanaan berikutnya
Dampak kejadian, informasi atau fakta
material tersebut terhadap kegiatan
operasional, hukum, kondisi keuangan,
atau kelangsungan usaha Emiten atau
Perusahaan Publik
Demikian untuk diketahui.
Hormat Kami,
Page 2
PT Bundamedik Tbk
Josephine Tobing
Corporate Secretary
PT Bundamedik Tbk
Jl. Teuku Cik Ditiro No. 28, Menteng
Telepon : (62-21) 3192-3344, Fax : (62-21) 3190-5915, www.bmhs.co.id
Nama Pengirim Josephine Tobing
Jabatan Corporate Secretary
Tanggal dan Waktu 23-04-2025 18:00
Lampiran 1. Surat Rencana Periode Pelaksanaan MESOP 2025.pdf
Dokumen ini merupakan dokumen resmi PT Bundamedik Tbk yang tidak memerlukan tanda tangan karena
dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Bundamedik Tbk bertanggung jawab penuh atas
informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 020-K/CORSEC/BMHS/IV/2025
Issuer Name PT Bundamedik Tbk
Issuer Code BMHS
Attachment 1
Subject Information on Planned Implementation Period of Phase I Window Exercise I
and Phase II Window Exercise I of 2025 Program Management and Employee
Stock Option Program (MESOP) of PT Bundamedik Tbk
The company hereby announce the Material Information or Facts Report as follows
Name of Issuer or Public Company PT Bundamedik Tbk
Business Activities Aktivitas rumah sakit swasta
Telephone (62-21) 3192-3344
Faximile (62-21) 3190-5915
Email Address corsec@bmhs.co.id
Date of Event 23 April 2025
Information on Planned Implementation Period of Phase I
Type of Material Information or Facts Window Exercise I and Phase II Window Exercise I of 2025
Program Management and Employee Stock Option Program
(MESOP) of PT Bundamedik Tbk
Description of Material Information or 1. Implementation Period of Phase I Window Exercise I and
Facts Phase II Window Exercise I : 30 (thirty) trading days from May
1st, 2025 to June 20th, 2025.
2. Pre-Set Execution Price of Phase I Window Exercise I : IDR
863 per shares
3. Pre-Set Execution Price of Phase II Window Exercise I : IDR
363 per shares
4. Number of Option Rights Converted For This Execution
Period of Phase I Window Exercise I : The maximum number
of Converted Option Rights for the Implementation Period is
22,500,000 shares and the Option Rights that have not been
converted in this Implementation Period can be exercised in
the next implementation period.
5. Number of Option Rights Converted For This Execution
Period of Phase II Window Exercise I : The maximum number
of Converted Option Rights for the Implementation Period is
2,500,000 shares and the Option Rights that have not been
converted in this Implementation Period can be exercised in
the next implementation period.
Impact of event, material information or
facts towards Issuers or Public
Company’s operational activities, legal,
financial condition, or going concern
Thus to be informed accordingly.
Respectfully,
PT Bundamedik Tbk
Page 4
Josephine Tobing
Corporate Secretary
PT Bundamedik Tbk
Jl. Teuku Cik Ditiro No. 28, Menteng
Phone : (62-21) 3192-3344, Fax : (62-21) 3190-5915, www.bmhs.co.id
Sender Name Josephine Tobing
Function Corporate Secretary
Date and Time 23-04-2025 18:00
Attachment 1. Surat Rencana Periode Pelaksanaan MESOP 2025.pdf
This is an official document of PT Bundamedik Tbk that does not require a signature as it was generated
electronically by the electronic reporting system. PT Bundamedik Tbk is fully responsible for the information
contained within this document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
unresolved
—
Josephine Tobing
· Corporate Secretary
p.2 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.